Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prelude Therapeutics Inc

0.7643
-0.0317-3.98%
Post-market: 0.76430.00000.00%16:20 EDT
Volume:54.88K
Turnover:42.76K
Market Cap:43.15M
PE:-0.46
High:0.8170
Open:0.7986
Low:0.7522
Close:0.7960
Loading ...
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2021

Major Issues Report

8-K - Current report
Mar 17, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2021

Major Issues Report

8-K - Current report
Mar 08, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 04, 2021

Major Issues Report

8-K - Current report
Jan 04, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Major Issues Report

8-K - Current report